Security key
10806X102
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 121,079,579
- Total 13F value
- $8,609,553,572
- Share change
- +2,410,737
- Put/Call ratio
- 35%
- SEC-reported price per share
- $71.11
- Number of holders
- 160
- Value change
- +$172,667,185
- Number of buys
- 98
- Number of sells
- 47
- Shares outstanding
- 196,245,202
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2020
Institutions
160
Top holders
10
BBIO full security history
Ownership snapshot
Full 13F holder table
BridgeBio Pharma, Inc. SEC filings
BridgeBio Pharma, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of BBIO - BridgeBio Pharma, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Kohlberg Kravis Roberts &...
Disclosed value leader
Kohlberg Kravis Roberts &...
Comparable rows
15/15
Latest evidence
30 Sep 2020
13F
Lead comparable stake: 18%
Showing 1-6 of 15 holder rows.
Quick read
Kohlberg Kravis Roberts & Co. L.P. leads the comparable SEC ownership view at 18%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Kohlberg Kravis Roberts & Co. L.P.'s linked filing trail.
Comparable ownership
Top 5
Kohlberg Kravis Roberts & Co. L.P.
18%
VIKING GLOBAL INVESTORS LP
14%
PERCEPTIVE ADVISORS LLC
3.4%
VANGUARD GROUP INC
3.2%
BlackRock Finance, Inc.
3.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Kohlberg Kravis Roberts & Co. L.P. |
13F
Company
|
18%
|
$1,294,852,000
34,510,971 shares
|
— | 30 Sep 2020 |
| VIKING GLOBAL INVESTORS LP |
13F
Company
|
14%
|
$998,820,000
26,620,991 shares
|
— | 30 Sep 2020 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
3.4%
|
$251,619,000
6,706,268 shares
|
— | 30 Sep 2020 |
| VANGUARD GROUP INC |
13F
Company
|
3.2%
|
$236,193,000
6,295,118 shares
|
— | 30 Sep 2020 |
| BlackRock Finance, Inc. |
13F
Company
|
3.1%
|
$229,627,000
6,120,137 shares
|
— | 30 Sep 2020 |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
Company
|
2.9%
|
$183,480,000
5,619,928 shares
|
— | 30 Sep 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
160
Shares
121,079,579
Rows available
160
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
128
Q4 2020 holders
160
Holder diff
32
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 value | Q4 2020 value | Value change | Value Chg % |
|---|